About Us |  Terms & Conditions |  Privacy Policy |  Refund & Cancellation |  Contact Us  
  Work Profile Neurorehabilitation Program Innovation and Research DRMK MEMORY FOUNDATION ARDSI-Nashik Books
 
National & Global recognition for Innovation in Mental Health & Healthcare Industry

“RASHTRIYA CHIKITSA RATAN AWARD, 2023”-– By National Achievers Recognition Forum at "Constitution Club of India", received by - Shri Ram Niwas Goel Ji- Honorable Speaker Delhi Vidhan Sabha, Shri Raaj Kumar Anand Ji - Cabinet Minister Social Welfare, Govt. Of Delhi, Shri. Vijender Garg Ji-Chairman Delhi Khadi & Village Industries Board, Govt. Of Delhi & Shri Dhirender Pratap Singh Ji - Former Minister Uttarakhand, New Delhi

“NATIONAL ACHIEVERS AWARD for HEALTH EXCELLENCE, 2023”-– By National Achievers Recognition Forum at "Constitution Club of India", received by - Shri Ram Niwas Goel Ji- Honorable Speaker Delhi Vidhan Sabha, Shri Raaj Kumar Anand Ji - Cabinet Minister Social Welfare, Govt. Of Delhi, Shri. Vijender Garg Ji-Chairman Delhi Khadi & Village Industries Board, Govt. Of Delhi and Shri Dhirender Pratap Singh Ji - Former Minister Uttarakhand New Delhi

"VOCATIONAL EXCELLENCE AWARD, 2023"-– By ROTARY CLUB OF PUNE Deccan Gymkhana, as a part of ROTARY INTERNATIONAL ORG. USA

GOLDEN AIM AWARDS FOR EXCELENCE AND LEADERSHIP IN HEALTHCARE - "WOMEN SUPER ACHIEVER AWARD-MENTAL HEALTH, 2022” – By Golden Aim Awards

WOMAN OF EXCELLENCE AWARDS 2021-22 – “WOMAN OF EXCELLENCE IN INNOVATION MAHARASHTRA STATE” BRAINOBRAIN, Maharashtra, INDIA affiliated to BRAINOBRAIN International.

INDIAN ACHIEVERS AWARD 2021-22 - "INDIAN ACHIEVERS’ AWARD 2021-22 - for Excellence in Healthcare”, for ‘‘Dr. Mangal Kardile’ by INDIAN ACHIEVERS’ FORUM initiated by Govt. of India

ASIA GCC AWARD - "ICONIC WOMEN LEADR AWARD-MENTAL HEALTH, 2021” – For Excellence & Leadership, for ‘‘Dr. Mangal Kardile’ by Golden Aim Asia GCC, FAMA

NATIONAL BEST RESEARCH PAPER AWARD - "BEST RESEARCH PAPER E-POSTER AWARD, 2021 –

9TH IFNRCON, Virtual conference April 10-11,2021 by IFNR & WFNR, AOSNR

GLOBAL AWARD - "WOMAN SUPER ACHEIVER AWARD, 2020” – 7th World Women Leadership Congress Awards, for ‘‘Dr. Mangal Kardile’ by CMO GLOBAL

GLOBAL AWARD FOR INNOVATIVE SERVICES IN MENTAL HEALTH - "Woman Super achiever Award, 2020", BY CMO Global, World Woman Leadership Congress & World Innovation Congress

GLOBAL AWARD FOR INNOVATION - for ‘Dr. Mangal Kardile’ Mental Health Aims, by “GOVT. OF INDIA – EXCELLENCE IN INNOVATION IN HEALTHCARE INDUSTRIES, MSME CCII GREENTECH ASIA AWARDS, 2020”, MSME Chamber of Commerce and Industries Govt. of India

NATIONAL AWARD FOR INNOVATION - "NEUROREHABILITATION INNOVATION OF THE YEAR AWARD, 2019” for ‘Dr. Mangal Kardile’ by INDIAN ACADEMY OF NEUROLOGISTS

NATIONAL AWARD - "NATIONAL HEALTHCARE LEADERSHIP- WOMEN LEADERSHIP AWARD 2019” for ‘‘Dr. Mangal Kardile’ by CMO ASIA

REGIONAL AWARD - "NASHIK HEALTHCARE LEADERSHIP AWARS, 2019” for ‘Mental Health Aims’ by World Health and Wellness Congress & World Sustainability Congress

GLOBAL AWARD - "100 MOST IMPACTFUL HEALTHCARE LEADERS [GLOBAL LISTING]", 2019 for Dr. Mangal Kardile by World Mental Health and Wellness Congress & World CSR Congress

REGIONAL AWARD -  Navdurga-Goddess “Kushmanda” Award for innovative work in mental health, 2018 for Dr. Mangal Kardile

NATIONAL AWARD - Mental Health Aims has been awarded “INDIA 5000 BEST MSME AWARDS, 2017” for services in mental health

INTERNATIONAL AWARDRESEARCH FUNDING AWARD for Dr. Mangal Kardile from “Capacity Australia” Sydney for standardization of “UMACE” memory and cognitive screening tool, 2015

 
 
 
UMACE – Universal Memory And Cognitive Exam (Standardized, 2015) With International research grant award, “Capacity Australia”.
(Screening test for memory and cognitive impairment, for post-Trauma neuropsychiatric evaluation, for Pre-Post-Epilepsy surgery neuropsychiatric evaluation)
 

Special edition – UMACE Neurological research studies

Background UMACE

The rationale behind developing the UMACE screening tool is to detect memory and cognitive deficits at an early stage. Understanding the utmost need for developing such an instrument that would detect cognitive impairments at an early stage and would be applicable to all population directed towards developing UMACE. The available screening tools such as MMSE have laid the foundations for neuropsychological testing and UMACE has been structured on the same foundation.

Currently used neuropsychological test instruments are not applicable to most of the population around the world as the assessment is based on restricted criteria. Many research studies done on the available neuropsychological test batteries as MMSE illustrate concerns about detecting cognitive impairments at an early stage and the flexibility of application for global population.

The UMACE test comprises many primary and complex cognitive tasks divided into two sections (Section 1 - Memory recall and basic cognitive domains, Section 2 - Complex cognitive functions and Motor functions) to be able to detect cognitive impairments at an early stage. Most of the population has been focused for this study is the patients with neurological disorders.

The initial development of UMACE started in June 2010 when it raised the need for an instrument that could be used to detect cognitive impairments in the illiterate population while developing a technology-based therapy for dementia. The therapy research work was carried out using available MMSE test with minimal number of participants and the research paper titled: “Cohesion of Cognitive and Technological inference for treating Dementia” was presented at - The Fifth International congress of the Asian Society Against Dementia, Jointly organized by - Asian Society against Dementia, The Chinese Dementia Research Association, The Hong Kong College of Psychiatrists— Hong Kong, Nov. 2011

The UMACE screening tool for memory and cognitive impairments has been developed in three different phases.

* First phase – Development of items with a screening tool kit with verbal and non-verbal tasks with the statistical assessment for tool validity, comparing UMACE with MMSE with two Normal sample groups (Literate and Illiterate N=78).

The research paper based on these studies was presented in Australia 2012

Title - “Using a Multicultural Model to develop a Universal Screening Tool for Cognitive and Memory Impairments” International Psychogeriatric Association International Meeting, Cairns, Australia, 7-11 September, 2012

* Second phase - The UMACE testing was performed for a group of 35 male and female patients with varied psychiatric disorders in a private psychiatric clinic using the original UMACE item structure and was compared with MMSE with a group of 35 male and female Normal population (N=70).

* Third phase - In the third phase different neurological disorder groups were administered in a private neurology clinic for 207 neurological disorder patients.

The additional test assessment functions are added in the third phase to assess the patients with Stroke or similar disorder having disabilities in speech and motor coordination.

The three-phase research work has been carried out in Nasik city, Maharashtra state, India by “Mental Health Aims”, the registered mental health service providers with the affiliation of private psychiatrists and neurologist.

The standardization process for the UMACE screening tool was carried out with the funding award from “Capacity Australia”, a NGO based in Sydney, Australia in 2014 and statistical procedure and research documentation was completed with the help of two Australian authors in 2015

The research paper titled “Excellence in diagnosis in culturally diverse settings: the development of Universal Memory And Cognitive Exam (UMACE), has been presented in the 26th Alzheimer Europe Conference at Copenhagen Denmark, 30th October-2nd November, 2016

Standardization of “UMACE”- Three phase statistical results were drawn between 2014-15, using ROC curve analysis focusing sensitivity and specificity of UMACE test. While standardizing the available new screening tests such as RUDAS & MCog were discussed, to know more refer to the full paper is published in 2018 in the International journal on the following link - http://www.ijhsr.org/IJHSR_Vol.8_Issue.5_May2018/35.pdf

The paper publication link is as follows

(Journal - International Journal of Health Sciences and Research)

http://www.ijhsr.org/IJHSR_Vol.8_Issue.5_May2018/35.pdf

* 26th Alzheimer Europe Conference “Excellence in dementia research and care” Copenhagen, Denmark (31 October- 2 November, 2016)

Presentation and online publication by Alzheimer Europe, Nov. 2016 -

P4.2. Mangal Kardile (India): Excellence in diagnosis in culturally diverse settings: the development of Universal Memory and Cognitive Exam (UMACE)

Online publication link - PPT published by Alzheimer’s Europe -

http://alzheimer-europe.org/Media/Files/7.-Conferences/2016-Copenhagen/P4.2-KARDILE-Mangal

* “Excellence in diagnosis in culturally diverse settings: the development of Universal Memory and Cognitive Exam (UMACE)”, Oral presentation at "The 26th Annual Conference of Alzheimer Europe", Copenhagen, Denmark from 31 Oct.–2 Nov.,2016. UMACE Research paper presentation PPT published by Alzheimer’s Europe http://alzheimer-europe.org/Media/Files/7.-Conferences/2016-Copenhagen/P4.2-KARDILE-Mangal

* 4th international conference on Vascular Dementia June 30-July 02, 2016 Valencia, Spain, Subcortical dementia developed at high altitude in Himalayas – an army case study investigation with MMSE and new UMACE diagnostic tool, Mangal Kardile, J Alzheimers Dis Parkinsonism 2016, 6:3(Suppl), http://dx.doi.org/10.4172/2161-0460.C1.019

* “Using a Multicultural Model to develop an Universal Diagnostic Tool for Cognitive and Memory Impairments”, International Psychogeriatric Association International Meeting, Cairns, Australia,7-11 September, 2012

In 2016, UMACE & UMACE-VIP, screening tests published and used at >11 Dist. Civil hospital Memory clinics, Maharashtra State, training is available for both tests (includes material & Technical manual). In 2019, Special edition of UMACE Neurological case studies available for purchase.

 

Copyright of Dr Mangal Kardile

Universal Memory And Cognitive ExamUMACE
Mentalhealthaims
 
Dr. Mangal Kardile (Founder-Mental Health Aims)
Director – DRMK MEMORY FOUNDATION
President – ARDSI Nashik Support Group
Medical Neuroscience, Duke University, USA (on Coursera)
MPsychClin, MPhil, PGDipPsychClin & IDMHL&HR

Research/ Work attention: Neuropsychology
Advocacy: Mental Health Law & Human Rights
Copyrights – “UMACE”, “UMACE-VIP”, “BrainNext”, “NeuroCog”
Home Work Profile Neurorehabilitation Program Innovation and Research DRMK MEMORY FOUNDATION Downloads Contact Us
Mental Health Aims